drugset / Trial / NCT04962152

Naldebain and Video-assisted Thoracoscopic Surgery

NCT04962152 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the postoperative analgesic effect of combined use of Naldebain® and thoracic paravertebral block in thoracoscopic surgery

Timeline

Start
2021-07-07
Primary completion
2024-05-07
Completion
2024-05-07

Outcome

Met primary endpoint

paper The mean fentanyl consumption over three days was significantly lower in the DS group (283 ± 70 µg) compared to the placebo group (708 ± 190 µg, P < 0.001). PMID 40382572 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinalbuphine sebacate Small molecule 150 mg Intramuscular

Indications

No indication recorded.